Available now!

Professor Vibeke Backer

Maximising the benefit of FeNO testing for airway inflammation in the daily clinic

We host quartely webinars (once every 3 months), this time its with Professor Njira Lugogo on The science behind FeNO testing and its clinical relevance in mild, moderate and severe asthma. Watch today! NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, with a simple touch screen interface and intuitive design, and can be used in a variety of settings, including clinics, hospitals, and primary care settings. The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals. Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive1 tool to help them better diagnose and manage asthma.

Enter your details to access on demand today:

Interpret FeNO

Use our online FeNO interpretation tool to understand your patients FeNO results.

Interpret FeNO

NIOX® Support

Learn about NIOX VERO®. Get technical information, customer support and education.

Visit NIOX® Support

Request a quote

Ready to use NIOX® in your practice? Use our onine quote tool to get started today.

Request a quote